IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Versant Venture Management, LLC

Q4 2014 Holdings

Filed 2015-04-02 | 5 holdings | $104.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2015-04-23) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Clovis Oncology, Inc.(CLVSEUR)Common Stock189464100$45.6M814,83343.6%
Five Prime Therapeutics, Inc.(FPRX)Common Stock33830X104$29.5M1,092,15228.2%
Achaogen, Inc.Common Stock004449104$16.7M1,281,15216.0%
CymaBay Therapeutics, Inc.(CBAYUSD)Common Stock23257D103$10.3M1,048,6019.9%
Inogen, Inc.(INGN)ACommon Stock45780L104$5.0M155,2844.4%
Kythera Biopharmaceuticals, Inc.Common Stock501570105$2.4M70,3762.3%